What is Vertex Pharmaceuticals's granted (in shares)?

Vertex Pharmaceuticals (VRTX) reported granted (in shares) of $125.74 in Q4 2025.

What does granted (in shares) mean?

The total number of shares issued or granted under specific equity compensation plans.

Vertex Pharmaceuticals Granted (in shares) remained flat by 0.0% to $125.74 in Q4 2025 compared to the prior quarter.

StatementIncome Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ1 2025

Last reportedQ4 2025Feb 13, 2026

Trends in share grants help investors model future share count dilution and assess the intensity of management's equity-based compensation.

This metric represents the aggregate number of shares granted under specific share-based payment arrangements, often use...

Standard disclosure for companies with active equity compensation programs.

Metric ID: other_share_based_compensation_arrangements_by_share_bas_099e66

1 years

	FY'25
Value	$502.97

What is Vertex Pharmaceuticals's granted (in shares)?: Vertex Pharmaceuticals (VRTX) reported granted (in shares) of $125.74 in Q4 2025.
What does granted (in shares) mean?: The total number of shares issued or granted under specific equity compensation plans.